SCHEMBL29628639

SCHEMBL29628639

CC(C=O)C(C(=O)O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.67
KMT2A Q03164 1/20 0.50
SRC P12931 1/20 0.48
LMNA P02545 4/20 0.46
MAPK1 P28482 2/20 0.46
PTGS2 P35354 3/20 0.44
APAF1 O14727 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MAPT P10636 2/20 0.42
PTGS1 P23219 2/20 0.42
CXCR1 P25024 2/20 0.42
CXCR2 P25025 2/20 0.42
RECQL P46063 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
PMP22 Q01453 1/20 0.42
SLC22A6 Q4U2R8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28006502 0.84 CYP2D6 (0.47) CYP2D6KMT2AMAPK1PTGS2SMN1; SMN2
SCHEMBL193565 0.82 CYP2D6 (0.73) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL5158960 0.82 CYP2D6 (0.73) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL66944 0.82 CYP2D6 (0.73) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL18321318 0.81 AKR1C3 (0.51) PTGS2PTGS1SLC22A6CYP1A2
SCHEMBL659768 0.81 CYP2D6 (1.00) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL11315838 0.81 CYP2D6 (1.00) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL7824857 0.81 CYP2D6 (1.00) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL7815004 0.81 CYP2D6 (1.00) CYP2D6KMT2ASRCLMNAMAPK1
SCHEMBL29628771 0.80 KMT2A (0.75) CYP2D6KMT2ALMNAPTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108779076-B 5-methyl-6-phenyl-4, 5-dihydro-2H-pyridazin-3-one derivatives 大塚制药株式会社 2022-05-03 CN disclosed